Company intelligence / Profile preview

BioAlert Solutions

Sherbrooke, Quebec, Canadabioalert.ca ↗

Ownership: Private
Development stage: Commercial

Overview

BioAlert Solutions has developed and commercialized the BioAlert Lp15, an automated, real-time water quality monitoring device that uses enhanced qPCR to detect Legionella in cooling towers and industrial water systems. The system provides same-day results within 4 hours, is fully autonomous, and is up to five times more sensitive than traditional laboratory methods. It is deployed across Canada and the US in hospitals, industrial facilities, and commercial buildings[1][2][5].

Therapeutic areas: Infectious Diseases
Modalities: DeviceDiagnostic technology (qPCR-based detection system)
Industry: Non-Drug Biotech

Partnerships

Cycle H20/Cycle Capital/H2O InnovationGreenSky VenturesFondactionSpring Impact Capital

Beyond the preview

Go deeper on BioAlert Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioAlert Solutions.

Explore the full profile